|Publication number||US20050080472 A1|
|Application number||US 10/736,863|
|Publication date||14 Apr 2005|
|Filing date||16 Dec 2003|
|Priority date||10 Oct 2003|
|Also published as||EP1722847A2, EP1722847A4, US7797053, US20060009830, WO2005053784A2, WO2005053784A3|
|Publication number||10736863, 736863, US 2005/0080472 A1, US 2005/080472 A1, US 20050080472 A1, US 20050080472A1, US 2005080472 A1, US 2005080472A1, US-A1-20050080472, US-A1-2005080472, US2005/0080472A1, US2005/080472A1, US20050080472 A1, US20050080472A1, US2005080472 A1, US2005080472A1|
|Inventors||Robert Atkinson, Peter Keith, Michael Berman|
|Original Assignee||Atkinson Robert Emmett, Keith Peter Trexler, Michael Berman|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (57), Referenced by (39), Classifications (11), Legal Events (1)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This application claims the benefit of U.S. Provisional Patent Application No. 60/510,663, filed Oct. 10, 2003, entitled LEAD STABILIZATION DEVICES AND METHODS to Atkinson et al., the entire disclosure of which is incorporated herein by reference.
The present invention generally relates to medical devices and methods. More specifically, the present invention relates to medical devices and methods for stabilizing leads in cardiac vasculature.
Heart failure is an increasingly common condition worldwide. Cardiac resynchronization therapy (CRT) has shown great promise as a treatment for a large percentage of patients in various stages of heart failure. CRT involves cardiac pacing of both the left and right ventricles of the heart (biventricular pacing), which causes both ventricles to beat simultaneously, greatly improving the pumping efficiency of the heart. Typically, the lead that stimulates the left ventricle is positioned via the coronary sinus into a cardiac vein along the free wall of the left ventricle.
There are numerous challenges in successfully positioning the left ventricular lead, including accessing the coronary sinus and veins, advancing the leads to a position which yields proper stimulation, and preventing subsequent lead dislodgement during removal of delivery devices. Post procedural challenges related to the left ventricular lead include lead dislodgement prior to fibrosis, loss of stimulation capture, and lead removal necessitated by infection.
Currently available left ventricular leads have generally been designed to facilitate effective delivery and provide fatigue resistance, and are particularly susceptible to dislodgement both intra-procedurally and post-procedurally. Efforts to incorporate more aggressive anchoring into the lead body have generally been insufficient for preventing dislodgment, and/or have compromised effective delivery, fatigue resistance and subsequent lead removal.
Therefore, a need exists to enable effective lead stabilization without compromising lead delivery, resistance to lead fatigue, or lead removal. To address this need, various exemplary non-limiting embodiments are described herein which provide devices and methods for acute and/or chronic lead stabilization. By way of example, not limitation, the lead stabilization mechanisms described herein may be separate from but cooperative with the lead, thus allowing independent delivery and function. To this end, the lead may be designed for effective delivery and fatigue resistance, and the stabilization mechanism may be designed for effective acute and/or chronic anchoring to prevent lead dislodgement. In addition, the stabilization mechanisms described herein may be separable from the lead to permit subsequent lead removal.
The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.
With reference to
Left ventricular leads are typically implanted with the proximal end connected to a pulse generator in a subcutaneous or submuscular pocket, and the distal end (electrode(s)) disposed in one of the cardiac veins to stimulate the left ventricle. The lead body typically extends from the pulse generator in the subcutaneous or submuscular pocket, through the vein wall and into the left subclavian vein (LSV), through the left brachio-cephalic vein (LBV), down the superior vena cava (SVC) and into the right atrium (RA), into the CS and into the target cardiac vein. The venous circulation is usually accessed by introducing delivery catheters (called guide catheters or guide sheaths) from a venous arteriotomy in the LSV to the CS ostium, following the dashed line shown in
There are generally two categories of LV leads, over-the-wire (OTW) leads and stylet-delivered leads. OTW leads incorporate a guide wire lumen which extends through the entire lead body, emerging at the tip of the lead. Navigation within the CS and cardiac veins is performed by advancing a steerable guide wire to a desired location in a cardiac vein, and the lead is then advanced over the guide wire. Stylet delivered leads have a stylet lumen which extends through the lead body, but typically terminates proximal of the distal tip. A shaped styled is positioned in the stylet lumen and the lead and stylet are advanced together to navigate the lead to a desired location in a cardiac vein.
Once the lead is positioned in a location that yields acceptable stimulation (capture), the delivery catheter is removed. Depending on the particular lead, and the type of electrical connector utilized, removal is accomplished either by withdrawing the delivery catheter over the proximal end of the lead, or by splitting the delivery catheter as it is removed over the proximal end of the lead. In some situations, removal of the delivery catheter may dislodge the lead, as the stability of the lead position is often quite tenuous. Even if the lead is not dislodged during removal of the delivery catheter, the beating of the heart and other patient activities can cause lead movement or dislodgement, leading to potential loss of capture (effective pacing of the LV).
With reference to
Lead 10 may comprises a conventional pacing lead having an elongate body or shaft 12 and one or more electrodes 14 connected to a pulse generator (not shown) by corresponding wires or traces inside the lead body 12. Lead 10 is generally designed to be very flexible and fatigue resistant to permit free cardiac movement, to minimize tissue trauma, and to withstand repeated flexure primarily caused by the beating heart. The electrodes 14 are typically positioned on or near the wall of the vein facing the heart to establish effective conduction into the heart wall.
Stent 20 may be self-expandable or balloon expandable, for example, and may be formed of a biocompatible metal material such as stainless steel, Nitinol, Elgiloy, or MP35N. Alternatively, stent 20 may be formed of a biodegradable polymeric material such as poly-L-lactic acid, polyglycolic acid, or polycaprolactone, or other biodegradable materials such as those used for biodegradable sutures. In the case of polymeric materials used for stent 20, the polymer may be loaded with a radiopaque agent such as barium, bismuth subcarbonate, etc. to facilitate x-ray visualization. Generally speaking, all of the anchors of the anchor devices described herein may be formed of the aforementioned materials and may be radiopaque.
Stent 20 may be connected to lead 10 by an elongate connector 30. Elongate connector 30 may comprise a tether that is flexible and fatigue resistant such as a braided cord of a high strength biocompatible polymer such as polyester, polypropylene, or polyethylene (e.g., Spectra brand), and may be partially or fully covered or coated with a material that promotes tissue in-growth such as ePTFE. The tissue in-growth promoting material may serve to secure the elongate member 30 to the lead 10 and/or prevent bacteria migration along the elongate member 30.
In the embodiment illustrated in
In this embodiment, the stent 20 and tether 30 may be deployed before the lead 10 is delivered. The stent 20 may be deployed in a distal portion of the target CV with a delivery device as described in more detail with reference to
If it is necessary or desired to remove or reposition the lead 10, the lead 10 may be removed from the CV by disconnecting the tether 30 from the lead 10 (e.g., by cutting the knot in the tether 30 at the proximal end of the lead 10), the tether 30 may be removed from the CV by disconnecting the tether 30 from the stent 20 (e.g., by using a cutting device as described in more detail with reference to
With reference to
The tether 30 may be connected to the lead 10 by a fastener such as collar 40. Collar 40 may comprise a short dual lumen tube including a relatively large lumen to accommodate the lead 10 therethrough and a relatively small lumen to accommodate the tether 30 therethrough. Collar 40 may be fixedly connected to the lead 10 if the anchor device is delivered prior to the lead 10 by swaging, adhesive, etc. To facilitate delivery of the lead after placement of the lead 10, the collar 40 may be slidable over the lead 10 and lock in place adjacent the distal potion of the lead 10 using a mating geometry such as a detent on the outer surface of the lead 10 that receives a protrusion extending from the inside surface of the collar 40. Alternatively, the outer surface of the lead 10 may include a protrusion such as a stepped ridge 45 that abuts the distal end of the collar 40 as the collar 40 is advanced over the lead 10 in order to prevent proximal movement of the lead 10 relative to the collar 40. With this alternative, the stepped ridge 45 may be an integral extension of the outer surface of the lead 10 or a separate component fixedly connected to the lead 10.
The tether 30 may be effectively connected to the collar 40 to prevent proximal movement of the collar 40 relative to the tether 30 by utilizing a knot or stop 35 that is slid down the length of the tether 30. A knot may be made in the tether at its proximal end and advanced distally to the collar 40 using a conventional knot pusher. A stop 35 may be used and configured to readily advance distally over the tether 30 and resist retraction proximally. For example, stop 35 may comprise a short tubular segment having proximal facing flanges extending from the inside surface that selectively engage the tether 30 only when the stop 35 is advanced in the proximal direction relative to the tether 30. To facilitate removal of the lead 10, the stop 35 may be cut or the tether 30 may be cut between the stop 35 and the collar 40 using the cutting device described with reference to
To facilitate advancement of the collar 40 over the lead 10 and to facilitate advancement of the stop 35 over the tether 35, a dual lumen advancement sheath 50 may be slid (pushed) over the lead 10 and tether 30. Sheath 50 may comprise an elongate dual lumen tube having a length sufficient to extend over the lead 10, through the venous vasculature, and out the venous access site, with one lumen to accommodate the lead 10 and another lumen to accommodate the tether 30. Sheath 50 may include a slit (not shown) along the length thereof to facilitate peeling over the lead 10. Sheath 50 may be removed over the lead 10 and tether 30 after advancement of the collar 40 and stop 35, or it may be left implanted to contain the tether 30 relative to the lead 10.
With reference to
With reference to
To facilitate delivery, a guide wire 130 may be used to initially navigate the CV. Once the guide wire 130 is in the desired position, the delivery catheter 100 with the pre-loaded stent 20 therein may then be advanced over the proximal end of the guide wire 130 and advanced thereover to the desired deployment position. The inner tube 110 may be advanced in the distal direction with respect to the outer tube 120 as indicated by arrow 115 to deploy the stent 20 in the CV. Once the stent 20 is deployed, the delivery catheter 100 may be removed.
With reference to
To accommodate delivery through the lumen extending through the lead 10, the coil 70 may have a delivery configuration wherein the coil 70 is elongated to have a reduced profile sufficiently small to fit into the lumen, and a deployed configuration wherein the coil 70 is radially expanded to have an expanded profile sufficiently large to frictionally engage the wall of the CV. The coil 70 may be highly elastic such that it assumes the deployed configuration automatically upon advancement out of the distal end of the lead 10, or the coil may be actuated (e.g., thermally) upon advancement out of the distal end of the lead 10 to assume the deployed configuration.
With reference to
With reference to
With reference to
With specific reference to
With specific reference to
With reference to
In this exemplary embodiment, cutting device 160 includes an outer tube 162 and an inner tube 164 coaxially disposed and movable therein. The outer and inner tubes 162 and 164 may have a length sufficient to extend from outside the vascular access site to the anchor device, and may be configured for intravascular navigation and advancement over tether 30. The distal end of the inner tube 164 may have a sharpened edge and may be formed of a material that retains a cutting edge (e.g., metal). A cutting hole 168 is provided adjacent the distal end of the outer tube 162 through which the tether 30 may be threaded. The distal circumference of the cutting hole 168 may be sharpened and may be formed of a material that retains a cutting edge (e.g., metal) After the cutting device is advanced over the tether 30 to the desired cutting site, the inner tube 164 may be advanced distally as indicated by arrow 166, with the sharpened distal end of the inner tube 164 and the sharpened cutting hole 168 acting as shears to cut the tether 30 at the cutting hole 168.
With reference to
Coil stent 200 may be formed of a resilient material such as Nitinol, Elgiloy, MP35N, or stainless steel. Coiled stent 200 could also be formed of degradable materials such as those described in reference to stent 20 above. Coiled stent 200 may be releasably attached to the lead 10 utilizing collar 210, and collar 210 may frictionally engage the body 12 of lead 10, thus facilitating anchoring of the lead within the coronary sinus or cardiac vein.
With reference to
To facilitate subsequent removal of the lead 10, the coiled stent 200 may be connected to the collar 210 in a detachable manner. For example, the coiled stent 200 may be connected to the collar 210 utilizing a biodegradable adhesive connecting adjacent portions of the coil 200 to the collar 210. Such an adhesive may degrade after the lead 10 has chronically anchored to the wall of the CS by normal tissue encapsulation. After the adhesive has degraded, the lead 10 (along with collar 210) may be removed utilizing standard techniques, with the coiled stent 200 remaining in the CS.
Alternatively, the coiled stent 200 may be secured to the collar 210 utilizing a retractable pin 220. In this alternative embodiment, collar 210 may include two angled flanges 214 collectively defining a recess 216 in which stent coil 200 may reside. Pin 220 may span the length of the recess 216 between the flanges 214, extending over the coiled stent 200 to retain the coil stent 200 in the recess 216, thus providing a connection between the stent coil 200 and the collar 214. Subsequent release of the stent coil 200 from the lead 10 may be accomplished by removing pin 220 using tether 30 which extends from the proximal end of the lead 10 to the pin 220. The proximal end of the pin 220 is connected to the distal end of the tether 30, and the pin 220 may be removed by pulling the tether 30 proximally. After the pin 220 is removed, the lead 10 and collar 210 are free from the stent coil 200 and may be removed with standard techniques, leaving stent coil 200 in the CS.
Delivery and deployment of the stent coil 200 and collar 210 may be facilitated by deployment sheath 230. The deployment sheath 230 may comprise a tubular catheter, having a lumen extending therethrough to accommodate the lead 10 and the stent coil 200. Alternatively, the lumen in the deployment sheath 230 may extend from a distal opening to a mid-shaft opening as used in conventional monorail style balloon catheters. After lead 10 has been positioned by standard techniques to a desired position, the stent coil 200 and collar 210 may be loaded on the proximal end of the lead 10. Coil 200 may be initially in a compressed condition, and loaded in the inside of the deployment sheath 230. If the lead 10 has a large diameter proximal connector, an optional slit 215 may be provided in the collar 220 to facilitate loading over the large diameter connector. In this case, the collar 210 and coil 200 may be positioned on the lead body 12 before the coil 200 is loaded into the deployment sheath 230. The deployment sheath 230 may be advanced distally down the body 12 of the lead 10 until the stent coil 200 and collar 210 are in the desirable location. The deployment sheath 230 may then be withdrawn proximally, with the collar 210 and stent coil 200 remaining in position on the lead 10 due to grips 218 on collar 210. As the stent coil 200 emerges from the deployment sheath 230, it expands to engage the wall of the CS. The deployment sheath 230 can then be removed from the lead 10.
In use, the anchoring catheter 300 is positioned next to the lead 10 after lead 10 has been positioned in a desired location. Anchoring catheter 300 may be advanced within the guide sheath (not shown), generally parallel to the lead body 12, or may be advanced outside the guide sheath. An expandable member such as a balloon 314 is inflated to frictionally secure lead 10 against the wall of the blood vessel. The guide sheath can then be removed without inadvertent dislodgement of the lead 10. The anchoring catheter 300 can then be removed. Since anchoring catheter 300 is next to and not surrounding the lead body 12, removal of the anchoring catheter 300 does not pose a risk of dislodging lead 10.
With particular reference to
Proximal shaft portion 312A may be relatively stiff and may be formed of a metallic tube such as a stainless steel hypotube. Distal shaft portion 312B may be relatively flexible and may be formed of a polymeric tube, for example. To facilitate advancement of the flexible distal shaft portion 312B and the balloon 314, a core wire may be connected to and extend from the distal end of the proximal shaft portion 312A. The core wire 320 may comprise a metal wire such as a tapered stainless steel mandrel.
Core wire 320 extends to the distal end of the balloon 314, and may extend beyond with an atraumatic spring tip, for example. The distal end of the balloon 314 may be bonded to the core wire 320, and the proximal end of the balloon 314 may be bonded to the distal end of the distal shaft portion 312B. Within the shaft 312 is a lumen through which inflation medium is infused to inflate balloon 314.
Those skilled in the art will recognize that the present invention may be manifested in a variety of forms other than the specific embodiments described and contemplated herein. Accordingly, departures in form and detail may be made without departing from the scope and spirit of the present invention as described in the appended claims.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US3664347 *||25 Jul 1969||23 May 1972||Dietrich Harmjanz||Electric heart stimulation method and electrode|
|US4258724 *||13 Apr 1979||31 Mar 1981||Synthelabo||Endocavitary cardiac stimulation probe|
|US4393883 *||3 Nov 1980||19 Jul 1983||Medtronic, Inc.||Single pass A-V lead|
|US4458677 *||19 Nov 1981||10 Jul 1984||Mccorkle Jr Charles E||Intravenous channel cardiac electrode and lead assembly and method|
|US4628944 *||7 Jan 1986||16 Dec 1986||Cordis Corporation||Cardiac pacing lead with biodegradable fixation structure|
|US5071407 *||12 Apr 1990||10 Dec 1991||Schneider (U.S.A.) Inc.||Radially expandable fixation member|
|US5170802 *||7 Jan 1991||15 Dec 1992||Medtronic, Inc.||Implantable electrode for location within a blood vessel|
|US5224491 *||30 Jun 1992||6 Jul 1993||Medtronic, Inc.||Implantable electrode for location within a blood vessel|
|US5231996 *||28 Jan 1992||3 Aug 1993||Medtronic, Inc.||Removable endocardial lead|
|US5246014 *||8 Nov 1991||21 Sep 1993||Medtronic, Inc.||Implantable lead system|
|US5531779 *||24 Jan 1995||2 Jul 1996||Cardiac Pacemakers, Inc.||Stent-type defibrillation electrode structures|
|US5755766 *||24 Jan 1997||26 May 1998||Cardiac Pacemakers, Inc.||Open-ended intravenous cardiac lead|
|US5902331 *||10 Mar 1998||11 May 1999||Medtronic, Inc.||Arrangement for implanting an endocardial cardiac lead|
|US5908447 *||6 Feb 1998||1 Jun 1999||Intermedics Inc.||Breakaway structure for body implantable medical device|
|US5925073 *||23 Feb 1998||20 Jul 1999||Cardiac Pacemakers, Inc.||Intravenous cardiac lead with wave shaped fixation segment|
|US5954761 *||25 Mar 1997||21 Sep 1999||Intermedics Inc.||Implantable endocardial lead assembly having a stent|
|US5964795 *||13 Mar 1998||12 Oct 1999||Medtronic, Inc.||Medical electrical lead|
|US5991668 *||25 Sep 1997||23 Nov 1999||Medtronic, Inc.||Medical electrical lead|
|US6070104 *||28 Nov 1997||30 May 2000||Medtronic, Inc.||Medical electrical right atrium and coronary sinus lead|
|US6094596 *||19 Jun 1998||25 Jul 2000||Angeron Corporation||Transvenous defibrillation lead system for use in middle cardiac vein|
|US6136021 *||23 Mar 1999||24 Oct 2000||Cardiac Pacemakers, Inc.||Expandable electrode for coronary venous leads|
|US6161029 *||8 Mar 1999||12 Dec 2000||Medtronic, Inc.||Apparatus and method for fixing electrodes in a blood vessel|
|US6178356 *||26 Mar 1999||23 Jan 2001||Cardiac Pacemakers, Inc.||Coronary venous lead having fixation mechanism|
|US6289251 *||1 Nov 1999||11 Sep 2001||Medtronic, Inc.||High strength medical electrical lead|
|US6321123 *||8 Mar 1999||20 Nov 2001||Medtronic Inc.||J-shaped coronary sinus lead|
|US6438427 *||20 Mar 2000||20 Aug 2002||Biotronik Mess-Und Therapiegerate Gmbh & Co. Ingenieurburo Berlin||Dilatable cardiac electrode arrangement for implantation in particular in the coronary sinus of the heart|
|US6445958 *||15 Apr 1999||3 Sep 2002||Intermedics, Inc.||Steerable coronary sinus defibrillation lead|
|US6504765 *||27 Dec 2001||7 Jan 2003||Hynix Semiconductor Inc.||Flash memory device and method of erasing the same|
|US6516230 *||26 Apr 2000||4 Feb 2003||Medtronic, Inc.||Medical electrical lead with fiber core|
|US6549812 *||29 Nov 1999||15 Apr 2003||Medtronic, Inc.||Medical electrical lead having bending stiffness which increase in the distal direction|
|US6632223 *||30 Mar 2000||14 Oct 2003||The General Hospital Corporation||Pulmonary vein ablation stent and method|
|US6697676 *||17 Apr 2001||24 Feb 2004||Medtronic, Inc.||Medical electrical lead having an expandable electrode assembly|
|US6711443 *||25 Jul 2001||23 Mar 2004||Oscor Inc.||Implantable coronary sinus lead and method of implant|
|US6714822 *||30 May 2002||30 Mar 2004||Medtronic, Inc.||Apparatus and method for expanding a stimulation lead body in situ|
|US6738674 *||28 Jan 2002||18 May 2004||Oscor Inc.||Implantable coronary sinus lead with mapping capabilities|
|US6745079 *||7 Nov 2001||1 Jun 2004||Medtronic, Inc.||Electrical tissue stimulation apparatus and method|
|US20010012958 *||18 Dec 2000||9 Aug 2001||Biotronik Mess -Und Berltherapiegeraete Gmbh & Co||Two-chamber single-pass electrode arrangement|
|US20020111663 *||28 Dec 2001||15 Aug 2002||Roger Dahl||System for providing electrical stimulation to a left chamber of a heart|
|US20020147487 *||5 Apr 2001||10 Oct 2002||Medtronic, Inc.||System and method for placing endocardial leads|
|US20020161423 *||27 Apr 2001||31 Oct 2002||Lokhoff Nicolaas M.||System and method for positioning an implantable medical device within a body|
|US20030023295 *||25 Jul 2001||30 Jan 2003||Osypka Thomas P.||Implantable coronary sinus lead|
|US20030083725 *||29 Oct 2001||1 May 2003||Berthold Kramm||Method and apparatus for endovenous pacing lead|
|US20030105506 *||4 Dec 2001||5 Jun 2003||Cardiac Pacemakers, Inc.||Apparatus and method for stabilizing an implantable lead|
|US20030171796 *||6 Mar 2002||11 Sep 2003||Medtronic, Inc.||Method and apparatus for placing a coronary sinus/cardiac vein pacing lead using a multi-purpose side lumen|
|US20030195603 *||7 May 2003||16 Oct 2003||Cardiac Pacemakers, Inc.||Leads for pacing and/or sensing the heart from within the coronary veins|
|US20030199961 *||3 Apr 2002||23 Oct 2003||Bjorklund Vicki L.||Method and apparatus for fixating a pacing lead of an implantable medical device|
|US20030203704 *||30 Apr 2002||30 Oct 2003||Roger Dahl||Apparatus and method for implanting an electrical lead|
|US20030204231 *||30 Apr 2002||30 Oct 2003||Hine Douglas S.||Method and apparatus for placing a coronary sinus/cardiac vein pacing and defibrillation lead with adjustable electrode spacing|
|US20030204234 *||30 Apr 2002||30 Oct 2003||Hine Douglas S.||Apparatus and method for fixedly engaging an electrical lead|
|US20040059404 *||24 Sep 2002||25 Mar 2004||Bjorklund Vicki L.||Deployable medical lead fixation system and method|
|US20040064024 *||30 Sep 2002||1 Apr 2004||Sommer John L.||Cardiac vein lead and guide catheter|
|US20040064172 *||26 Sep 2002||1 Apr 2004||Mcvenes Rick D.||Medical lead with flexible distal guidewire extension|
|US20040064173 *||27 Sep 2002||1 Apr 2004||Hine Douglas S.||Cardiac vein lead with flexible anode and method for forming same|
|US20040068312 *||25 Apr 2003||8 Apr 2004||Medtronic, Inc.||Delivery of active fixation implatable lead systems|
|US20040116965 *||11 Dec 2002||17 Jun 2004||Eric Falkenberg||Atrial fibrillation therapy with pulmonary vein support|
|US20050033394 *||8 Aug 2003||10 Feb 2005||Medtronic, Inc.||Medical electrical lead anchoring|
|US20050137674 *||22 Oct 2004||23 Jun 2005||Cardiac Pacemakers, Inc.||Distal or proximal fixation of over-the-tether myocardial leads|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US7330765||25 Apr 2005||12 Feb 2008||Cardiac Pacemakers, Inc.||Cardiac lead having self-expanding fixation features|
|US7477946||26 Apr 2005||13 Jan 2009||Cardiac Pacemakers, Inc.||Fixation device for coronary venous lead|
|US7616992||30 Jan 2006||10 Nov 2009||Medtronic, Inc.||Intravascular medical device|
|US7627376 *||30 Jan 2006||1 Dec 2009||Medtronic, Inc.||Intravascular medical device|
|US7662132||25 Jan 2007||16 Feb 2010||Cardiac Pacemakers, Inc.||Expandable member for venous lead fixation|
|US7734343||31 May 2006||8 Jun 2010||Synecor, Llc||Implantable intravascular device for defibrillation and/or pacing|
|US7747335||10 Dec 2004||29 Jun 2010||Synecor Llc||Implantable medical device having pre-implant exoskeleton|
|US7801627||17 Dec 2007||21 Sep 2010||Cardiac Pacemakers, Inc.||Cardiac lead having self-expanding fixation features|
|US7840282||20 Jul 2009||23 Nov 2010||Synecor Llc||Method and apparatus for retaining medical implants within body vessels|
|US7865249 *||22 Sep 2006||4 Jan 2011||Cardiac Pacemakers, Inc.||Means to securely fixate pacing leads and/or sensors in vessels|
|US7899554||30 Oct 2007||1 Mar 2011||Synecor Llc||Intravascular System and Method|
|US7917230 *||30 Jan 2007||29 Mar 2011||Cardiac Pacemakers, Inc.||Neurostimulating lead having a stent-like anchor|
|US7949409||30 Jan 2007||24 May 2011||Cardiac Pacemakers, Inc.||Dual spiral lead configurations|
|US8000810||20 Mar 2007||16 Aug 2011||Cardiac Pacemakers, Inc.||Systems and methods for transvenous lead implantation|
|US8078279 *||19 Nov 2009||13 Dec 2011||Dennis Charles L||Intravascular medical device|
|US8126571||15 Jun 2009||28 Feb 2012||Cardiac Pacemakers, Inc.||Expandable assembly for cardiac lead fixation|
|US8175724||17 Dec 2008||8 May 2012||Cardiac Pacemakers, Inc.||Vascular fixation device|
|US8244378||30 Jan 2007||14 Aug 2012||Cardiac Pacemakers, Inc.||Spiral configurations for intravascular lead stability|
|US8311633 *||4 Dec 2007||13 Nov 2012||Synecor Llc||Intravascular implantable device having superior anchoring arrangement|
|US8532789 *||28 Feb 2006||10 Sep 2013||Medtronic, Inc.||Subcutaneous lead fixation mechanisms|
|US8676349||14 Sep 2007||18 Mar 2014||Cardiac Pacemakers, Inc.||Mechanism for releasably engaging an implantable medical device for implantation|
|US8712553||7 Dec 2010||29 Apr 2014||Cardiac Pacemakers, Inc.||Means to securely fixate pacing leads and/or sensors in vessels|
|US8974509 *||27 Jan 2006||10 Mar 2015||Biosensors International Group, Ltd.||Pass-through restraint electrolytic implant delivery systems|
|US9026229||14 Mar 2014||5 May 2015||Cardiac Pacemakers, Inc.||Mechanism for releasably engaging an implantable medical device for implantation|
|US9072897||23 Oct 2013||7 Jul 2015||Mainstay Medical Limited||Systems and methods for restoring muscle function to the lumbar spine|
|US9079019 *||1 Aug 2012||14 Jul 2015||Mainstay Medical Limited||Apparatus and methods for anchoring electrode leads for use with implantable neuromuscular electrical stimulator|
|US9108025 *||8 Oct 2009||18 Aug 2015||Gardia Medical Ltd.||Apparatus and method for anchoring an elongated object in body lumens|
|US20040249431 *||4 Jun 2003||9 Dec 2004||Terrance Ransbury||Device and method for retaining a medical device within a vessel|
|US20050154437 *||10 Dec 2004||14 Jul 2005||Williams Michael S.||Implantable medical device having pre-implant exoskeleton|
|US20050228471 *||29 Oct 2004||13 Oct 2005||Williams Michael S||Method and apparatus for retaining medical implants within body vessels|
|US20050234431 *||10 Feb 2005||20 Oct 2005||Williams Michael S||Intravascular delivery system for therapeutic agents|
|US20070100418 *||27 Jan 2006||3 May 2007||David Licata||Pass-through restraint electrolytic implant delivery systems|
|US20110106120 *||16 Jan 2009||5 May 2011||Med Institute, Inc.||Intravascular device attachment system having tubular expandable body|
|US20110224769 *||8 Oct 2009||15 Sep 2011||Gardia Medical Ltd.||Apparatus and method for anchoring an elongated object in body lumens|
|US20130131766 *||23 May 2013||Peter Andrew Crosby||Apparatus and methods for anchoring electrode leads for use with implantable neuromuscular electrical stimulator|
|WO2006116205A1||24 Apr 2006||2 Nov 2006||Cardiac Pacemakers Inc||Cardiac lead having self-expanding fixation features|
|WO2006116284A2||24 Apr 2006||2 Nov 2006||Cardiac Pacemakers Inc||Fixation device for coronary venous lead|
|WO2008091886A1||22 Jan 2008||31 Jul 2008||Cardiac Pacemakers Inc||Expandable member for venous lead fixation|
|WO2010039853A1 *||30 Sep 2009||8 Apr 2010||Inspire Medical Systems, Inc.||Transvenous method of treating sleep apnea|
|International Classification||A61F2/86, A61N1/05|
|Cooperative Classification||A61F2230/0076, A61F2230/005, A61F2220/0008, A61F2/86, A61F2/95, A61N1/057|
|European Classification||A61N1/05N4, A61F2/86|
|16 Dec 2003||AS||Assignment|
Owner name: AETHERWORKS I, INC., MINNESOTA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ATKINSON, ROBERT E.;KEITH, PETER T.;BERMAN, MICHAEL;REEL/FRAME:014804/0692
Effective date: 20031212